| ASSET | MONTH | % RETURN |
|---|---|---|
QXO (QXO) | April 2012 | 204,260.23% |
QXO (QXO) | March 2012 | 687.5% |
QXO (QXO) | January 2012 | 100% |
Netflix (NFLX) | January 2012 | 71.03% |
Illumina (ILMN) | January 2012 | 67.29% |
Celsius (CELH) | March 2012 | 66.63% |
American Airlines (AAL) | January 2012 | 62.31% |
Regeneron Pharmaceuticals (REGN) | January 2012 | 60.79% |
Alnylam Pharmaceuticals (ALNY) | July 2012 | 60.57% |
Vertex Pharmaceuticals (VRTX) | May 2012 | 56.35% |
Genmab A-S (GMAB) | July 2012 | 55.96% |
Insmed (INSM) | January 2012 | 54.49% |
QXO (QXO) | December 2012 | 50% |
XPO Logistics (XPO) | February 2012 | 45.83% |
Netflix (NFLX) | October 2012 | 45.13% |
EPAM Systems (EPAM) | March 2012 | 45.02% |
T-Mobile US (TMUS) | July 2012 | 44.32% |
Cheniere Energy (LNG) | January 2012 | 43.87% |
Nomura Holdings Inc ADR (NMR) | December 2012 | 43.45% |
QXO (QXO) | September 2012 | 42.86% |
Constellation Brands Inc Class A (STZ) | June 2012 | 42.57% |
Coeur Mining (CDE) | August 2012 | 42.09% |
Celsius (CELH) | May 2012 | 40.78% |
Insmed (INSM) | October 2012 | 40.75% |
Insmed (INSM) | September 2012 | 40% |
Large-cap stocks are treated as having a market cap of $10B+.
